REVLIMID Reviews (LENALIDOMIDE)

Average Rating: 4.3 (3 Ratings)

Filter Results

Compare REVLIMID with similar:

 Type: Rx Drug

  

REVLIMID  (LENALIDOMIDE):  Lenalidomide is used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication.   FDA Approval Date: 2006-06-29 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR REVLIMIDCOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 4  MULTIPLE MYELOMA Revlimid, given in 21 days on/ 7 days off, has kept me is very good partial remission for 3 years since my stem cell transplant. I have very few side effects except tiredness and some bone pain. Part of these "side effects" could be attributable to the fact that I am a cancer patient and have had a stem cell transplant. In all, this drug has been good for me so far. Celgene has been a good company to work with as far as providing financial assistance for the drug. This brings the price down to an affordable co-pay that is about the same as what I pay for my blood pressure medication. F 46 3 years
10 MG 1X day		 4/18/2017
Email
 5  Multiple Myeloma Chronic fatigue but may not be caused by Revlimid This drug is amazing. It put me in total remission on 1/9/13. F 47 2 years
5 mg 1X day		 1/11/2013
Email
 4  Multiple Myeloma Foods have bland taste and very mild neuropathy in feet at night. F 45 7 days
10 1X day		 6/3/2010
  

REVLIMID  (LENALIDOMIDE):  Lenalidomide is used to treat certain cancers (multiple myeloma, mantle cell lymphoma-MCL). It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication.   FDA Approval Date: 2006-06-29 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP